Search Browse Earnings

Ceribell, Inc. — SlamSEC

Ceribell, Inc.

Nasdaq:CBLL

Electromedical & Electrotherapeutic Apparatus·SUNNYVALE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$65.4M

+44.7% YoY

FY 2025

Adj. EBITDA

-$38.6M

-58.9% margin

FY 2025

Net Income

-$40.5M

-61.8% margin

FY 2025

EPS (Diluted)

-$3.39

FY 2025

Stock Price

$18.42

+0.9%

2026-03-10

52W Range

$10.01 – $24.33

P/E Ratio

-5.4x

Market Cap

$693.4M

Cash

$194.4M

FY 2025

Total Debt

$31.4M

FY 2025

Net Cash

$163.0M

FY 2025

Enterprise Value

$530.4M

Debt / EBITDA

4.2x

FY 2025

EV / EBITDA

-13.8x

Employees

—